Alpha Clinic
The Alpha Clinic at Cedars-Sinai pioneers regenerative medicine, specializing in cutting-edge cell and gene therapies with a focus on disorders with unmet medical needs. With decades of combined experience, our team engages in the development and execution of regenerative medicine clinical trials. The Alpha Clinic at Cedars-Sinai is part of a network supported by the California Institute for Regenerative Medicine (CIRM).
Aims
Operating under ethical standards, regulatory compliance and scientific rigor, our Alpha Clinic ensures the integrity and reliability of clinical trials. This commitment aligns with our aims to:
Expand patients' access to stem cell and gene therapies
Increase research and training in regenerative medicine
Foster greater collaboration with the other CIRM Alpha Clinics across the state
Promote public and healthcare education on stem cell and gene therapies and advance careers in regenerative medicine through training.
What We Do
- Clinical Trial Services: Conduct academic and industry-sponsored cell and gene therapy trials.
- Biomanufacturing Facility: Cedars-Sinai has a state-of-the-art cGMP facility, specializing in manufacturing cell therapies for clinical trials.
- Data Management and Computational Biomedicine: Expertise in computational biomedicine to manage data through informatics, artificial intelligence and machine learning techniques.
- Advanced Proteomic Capabilities: Including single-cell assays for a comprehensive understanding of disease pathobiology, biomarker identification, and responses to regenerative medicine.
- Advanced Imaging: Cutting-edge imaging solutions for both preclinical and clinical studies enhance precision and depth of analysis.
- Master’s degree program in Regenerative Medicine: Fostering education and expertise in the field (coming soon).
Request Our Services
Whether you're a patient seeking transformative care or a researcher aiming for breakthroughs, our services are tailored to your needs. To initiate any of these services, please send us a message to get started.
Active Clinical Trial
Our researchers are studying the safety and efficacy of genetically engineered neural progenitor cells (CNS10-NPC-GDNF) that produce the growth factor GDNF. Focused on ALS patients with symptoms for less than 3 years, the goal is to protect damaged motor neurons.
Alpha Clinic News and Updates
Have Questions or Need Help?
Contact us if you have questions or to learn more about the Alpha Clinic at Cedars-Sinai Regenerative Medicine Institute.